Ascorbic Acid on Restenosis of Dysfunctional Hemodialysis Vascular Access

NCT03524846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Hemodialysis Access Failure

Interventions

DRUG: Ascorbic Acid 300 MG
DRUG: Ascorbic Acid 600 MG
DRUG: Normal saline

Sponsor

National Taiwan University Hospital Hsin-Chu Branch